Palliative and End-of-Life Care in Myelodysplastic Syndromes

Myles Nickolich, Areej El-Jawahri, Thomas W. LeBlanc

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

A growing literature demonstrates that MDS is associated with significant impairments in overall quality of life. Given the poor prognosis for many patients with MDS, and the considerable morbidities associated with this disease, there is a critical need to address palliative and end-of-life care needs in this population. However, palliative and end-of-life care issues are under-represented in the MDS literature. In this article, we highlight a growing body of literature that demonstrates unmet palliative and end-of-life care needs in hematologic malignancies, including MDS, and highlight opportunities for further research and quality improvement initiatives to address unmet needs in MDS care.

Original languageEnglish (US)
Pages (from-to)434-440
Number of pages7
JournalCurrent Hematologic Malignancy Reports
Volume11
Issue number6
DOIs
StatePublished - Dec 1 2016

Fingerprint

Terminal Care
Myelodysplastic Syndromes
Hematologic Neoplasms
Quality Improvement
Quality of Life
Morbidity
Research
Population

All Science Journal Classification (ASJC) codes

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Nickolich, Myles ; El-Jawahri, Areej ; LeBlanc, Thomas W. / Palliative and End-of-Life Care in Myelodysplastic Syndromes. In: Current Hematologic Malignancy Reports. 2016 ; Vol. 11, No. 6. pp. 434-440.
@article{e40e6e7389d84a5fa3946bddd900780d,
title = "Palliative and End-of-Life Care in Myelodysplastic Syndromes",
abstract = "A growing literature demonstrates that MDS is associated with significant impairments in overall quality of life. Given the poor prognosis for many patients with MDS, and the considerable morbidities associated with this disease, there is a critical need to address palliative and end-of-life care needs in this population. However, palliative and end-of-life care issues are under-represented in the MDS literature. In this article, we highlight a growing body of literature that demonstrates unmet palliative and end-of-life care needs in hematologic malignancies, including MDS, and highlight opportunities for further research and quality improvement initiatives to address unmet needs in MDS care.",
author = "Myles Nickolich and Areej El-Jawahri and LeBlanc, {Thomas W.}",
year = "2016",
month = "12",
day = "1",
doi = "10.1007/s11899-016-0352-z",
language = "English (US)",
volume = "11",
pages = "434--440",
journal = "Current Hematologic Malignancy Reports",
issn = "1558-8211",
publisher = "Springer Science + Business Media",
number = "6",

}

Palliative and End-of-Life Care in Myelodysplastic Syndromes. / Nickolich, Myles; El-Jawahri, Areej; LeBlanc, Thomas W.

In: Current Hematologic Malignancy Reports, Vol. 11, No. 6, 01.12.2016, p. 434-440.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Palliative and End-of-Life Care in Myelodysplastic Syndromes

AU - Nickolich, Myles

AU - El-Jawahri, Areej

AU - LeBlanc, Thomas W.

PY - 2016/12/1

Y1 - 2016/12/1

N2 - A growing literature demonstrates that MDS is associated with significant impairments in overall quality of life. Given the poor prognosis for many patients with MDS, and the considerable morbidities associated with this disease, there is a critical need to address palliative and end-of-life care needs in this population. However, palliative and end-of-life care issues are under-represented in the MDS literature. In this article, we highlight a growing body of literature that demonstrates unmet palliative and end-of-life care needs in hematologic malignancies, including MDS, and highlight opportunities for further research and quality improvement initiatives to address unmet needs in MDS care.

AB - A growing literature demonstrates that MDS is associated with significant impairments in overall quality of life. Given the poor prognosis for many patients with MDS, and the considerable morbidities associated with this disease, there is a critical need to address palliative and end-of-life care needs in this population. However, palliative and end-of-life care issues are under-represented in the MDS literature. In this article, we highlight a growing body of literature that demonstrates unmet palliative and end-of-life care needs in hematologic malignancies, including MDS, and highlight opportunities for further research and quality improvement initiatives to address unmet needs in MDS care.

UR - http://www.scopus.com/inward/record.url?scp=84990817514&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84990817514&partnerID=8YFLogxK

U2 - 10.1007/s11899-016-0352-z

DO - 10.1007/s11899-016-0352-z

M3 - Review article

C2 - 27704467

AN - SCOPUS:84990817514

VL - 11

SP - 434

EP - 440

JO - Current Hematologic Malignancy Reports

JF - Current Hematologic Malignancy Reports

SN - 1558-8211

IS - 6

ER -